Expression of bcl-2 protein in chronic hepatitis C: Effect of interferon alpha 2b with ribavirin therapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 19

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

269

HTML

1888

Tables (1-3)

121

Sum=2278

May 21, 2005 (publication date) through May 2, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. May 21, 2005; 11(19): 2949-2952
Published online May 21, 2005. doi: 10.3748/wjg.v11.i19.2949

Table 2 Expression of bcl-2 protein on hepatocytes and lymphocytes in liver tissue before and after treatment with IFNα2b and RBV (mean±SD).

Chronic hepatitis C, total, n = 30	Before treatment	After treatment	P
Hepatocytes (%)	92±12	87±11	<0.05
Liver-associated lymphocytes (%)	37±26	27±21	NS
Responders, n = 10
Hepatocytes (%)	87±15	83±20	NS
Liver-associated lymphocytes	28±18	26±10	NS
Non-responders, n = 20
Hepatocytes (%)	94±32	88±21	<0.05
Liver-associated lymphocytes (%)	39±29	28±12	NS

Citation: Anatol P, Danuta P, Janusz D, Bozena P. Expression of bcl-2 protein in chronic hepatitis C: Effect of interferon alpha 2b with ribavirin therapy. World J Gastroenterol 2005; 11(19): 2949-2952
URL: https://www.wjgnet.com/1007-9327/full/v11/i19/2949.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i19.2949